Status:
COMPLETED
hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Fertility Agents, Female
Eligibility:
FEMALE
18-45 years
Phase:
PHASE2
Brief Summary
The implantation rate after frozen-thawed embryo transfer cycles depends mostly on the receptivity of the endometrium and the embryo quality.The effects of human chorionic gonadotropins (hCG) on the e...
Eligibility Criteria
Inclusion
- all women on frozen-thawed embryo-transfer cycle
Exclusion
- any allergy to injection of human chorionic gonadotropin before
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2008
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00398229
Start Date
November 1 2006
End Date
May 1 2008
Last Update
January 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical center
Jerusalem, Israel